Search research articles
Contact Us
Filters
Showing results (151-160 of 156) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 156 results.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2020
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer
Bradford A Perez, Sungjune Kim, Minhsuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer
Ritu Chaudhary, Graydon Moorhead, Robin Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 19, 2023
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
Casey L Liveringhouse, Kujtim Latifi, Amalin G Asous, et al.
Gut
|
December 10, 2024
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer
Ramani Soundararajan, Michelle M Maurin, Jetsen Rodriguez-Silva, et al.
Blood
|
June 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention
Joseph A Pidala, Nicoletta Cieri, Michael J Schell, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 156) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 156 results.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2020
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer
Bradford A Perez, Sungjune Kim, Minhsuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer
Ritu Chaudhary, Graydon Moorhead, Robin Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 19, 2023
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
Casey L Liveringhouse, Kujtim Latifi, Amalin G Asous, et al.
Gut
|
December 10, 2024
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer
Ramani Soundararajan, Michelle M Maurin, Jetsen Rodriguez-Silva, et al.
Blood
|
June 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention
Joseph A Pidala, Nicoletta Cieri, Michael J Schell, et al.
Page
of 16